News
9h
Pharmaceutical Technology on MSNMHRA authorises Bavarian Nordic’s chikungunya virus vaccineThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Bavarian Nordic's ...
Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (1 May 2025) approved a vaccine (Vimkunya) used to ...
Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.
The UK Health Security Agency said the number of serious illnesses infecting UK holidmakers has soared in the last 12 months ...
4d
Pharmaceutical Technology on MSNFrance halts Valneva’s chikungunya vaccine use in seniorsFrench health authorities have suspended the use of Valneva’s chikungunya vaccine Ixchiq in adults aged 65 and older after ...
Valneva said it has been supplying Ixchiq to help the French government respond to a major outbreak of chikungunya in La ...
Shares in Valneva plunged after the company said France's health authorities suspended the use of its chikungunya vaccine, Ixchiq, for people aged 65 and older, raising concerns about the vaccine's ...
The country is considered the epicenter of the disease in the Americas, with epidemics reported over the years.
Mosquito-borne diseases like Malaria, Dengue, and Chikungunya are common in warm areas. Though similar in symptoms, they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results